363 related articles for article (PubMed ID: 27342458)
1. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.
Lazúrová I; Tomáš Ľ
Clin Rev Allergy Immunol; 2017 Jun; 52(3):323-332. PubMed ID: 27342458
[TBL] [Abstract][Full Text] [Related]
2. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
5. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients.
Rodríguez-Carrio J; Alperi-López M; López P; Ballina-García FJ; Abal F; Suárez A
Transl Res; 2015 Dec; 166(6):529-39. PubMed ID: 26279255
[TBL] [Abstract][Full Text] [Related]
8. [Inflammation-related cardiovascular morbidity : Pathophysiology and therapy].
Fischer-Betz R; Halle M; Schneider M
Z Rheumatol; 2010 Oct; 69(8):680-4, 686-8. PubMed ID: 20862480
[TBL] [Abstract][Full Text] [Related]
9. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
10. Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases.
Mackey RH; Kuller LH; Moreland LW
Rheum Dis Clin North Am; 2018 Aug; 44(3):475-487. PubMed ID: 30001787
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease in rheumatoid arthritis.
Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Garcia-Porrua C; Llorca J; Martin J
Biomed Pharmacother; 2006 Dec; 60(10):673-7. PubMed ID: 17049201
[TBL] [Abstract][Full Text] [Related]
12. Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks.
Zoli A; Bosello S; Comerci G; Galiano N; Forni A; Loperfido F; Ferraccioli GF
Rheumatol Int; 2017 Jan; 37(1):13-19. PubMed ID: 26586235
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
Jurcuţ C; Jurcuţ R; Tănăsescu C
Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
[TBL] [Abstract][Full Text] [Related]
14. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease in patients with rheumatoid arthritis.
Liao KP
Trends Cardiovasc Med; 2017 Feb; 27(2):136-140. PubMed ID: 27612551
[TBL] [Abstract][Full Text] [Related]
16. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis.
Targońska-Stepniak B; Drelich-Zbroja A; Majdan M
J Clin Rheumatol; 2011 Aug; 17(5):249-55. PubMed ID: 21778898
[TBL] [Abstract][Full Text] [Related]
17. [Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].
Skrzypek A; Nessler J
Przegl Lek; 2014; 71(7):378-83. PubMed ID: 25338333
[TBL] [Abstract][Full Text] [Related]
18. [Rheumatoid arthritis: a cardiovascular disease?].
Daïen CI; Fesler P
Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
[TBL] [Abstract][Full Text] [Related]
19. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis.
Rodríguez-Carrio J; Alperi-López M; López P; Alonso-Castro S; Carro-Esteban SR; Ballina-García FJ; Suárez A
Atherosclerosis; 2015 May; 240(1):131-6. PubMed ID: 25778627
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular involvement in rheumatoid arthritis.
Gerli R; Goodson NJ
Lupus; 2005; 14(9):679-82. PubMed ID: 16218466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
